270 related articles for article (PubMed ID: 18459517)
21. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
Emer J; Sundaram H
J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
[TBL] [Abstract][Full Text] [Related]
22. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.
Mayer RD; Dmochowski RR; Appell RA; Sand PK; Klimberg IW; Jacoby K; Graham CW; Snyder JA; Nitti VW; Winters JC
Urology; 2007 May; 69(5):876-80. PubMed ID: 17482925
[TBL] [Abstract][Full Text] [Related]
23. Malar augmentation with a polymethylmethacrylate-enhanced filler: assessment of a 12-month open-label pilot study.
Mills DC; Camp S; Mosser S; Sayeg A; Hurwitz D; Ronel D
Aesthet Surg J; 2013 Mar; 33(3):421-30. PubMed ID: 23515386
[TBL] [Abstract][Full Text] [Related]
24. Hand recontouring with calcium hydroxylapatite (Radiesse).
Edelson KL
J Cosmet Dermatol; 2009 Mar; 8(1):44-51. PubMed ID: 19250166
[TBL] [Abstract][Full Text] [Related]
25. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
[TBL] [Abstract][Full Text] [Related]
26. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
[TBL] [Abstract][Full Text] [Related]
27. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results.
Bass LS; Smith S; Busso M; McClaren M
Aesthet Surg J; 2010 Mar; 30(2):235-8. PubMed ID: 20442101
[TBL] [Abstract][Full Text] [Related]
28. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.
Marmur E; Green L; Busso M
Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272
[TBL] [Abstract][Full Text] [Related]
29. Injectable calcium hydroxylapatite microspheres (Radiesse).
Ridenour B; Kontis TC
Facial Plast Surg; 2009 May; 25(2):100-5. PubMed ID: 19415577
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
Roy D; Sadick N; Mangat D
Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
[TBL] [Abstract][Full Text] [Related]
31. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report.
Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; Zraick RI
Laryngoscope; 2009 May; 119(5):1033-41. PubMed ID: 19274731
[TBL] [Abstract][Full Text] [Related]
32. Calcium hydroxylapatite filler: an overview of safety and tolerability.
Pavicic T
J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
[TBL] [Abstract][Full Text] [Related]
33. Vocal fold augmentation with calcium hydroxylapatite.
Belafsky PC; Postma GN
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):351-4. PubMed ID: 15467598
[TBL] [Abstract][Full Text] [Related]
34. High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
Pignatti M; Pedone A; Baccarani A; Guaraldi G; Orlando G; Lombardi M; De Santis G
Aesthetic Plast Surg; 2012 Feb; 36(1):180-5. PubMed ID: 21717261
[TBL] [Abstract][Full Text] [Related]
35. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
[TBL] [Abstract][Full Text] [Related]
36. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
Jacovella PF
Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
[TBL] [Abstract][Full Text] [Related]
37. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life.
van Rozelaar L; Kadouch JA; Duyndam DA; Nieuwkerk PT; Lutgendorff F; Karim RB
Aesthet Surg J; 2014 Jan; 34(1):118-32. PubMed ID: 24334306
[TBL] [Abstract][Full Text] [Related]
38. Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation.
Fabi SG; Alhaddad M; Boen M; Goldman M
J Drugs Dermatol; 2021 May; 20(5):534-537. PubMed ID: 33938688
[TBL] [Abstract][Full Text] [Related]
39. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.
Alam M; Yoo SS
J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371
[TBL] [Abstract][Full Text] [Related]
40. Patient satisfaction following Bio-Alcamid injection for facial contour defects.
George DA; Erel E; Waters R
J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1622-6. PubMed ID: 22749703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
